CDTX vs XLV
Cidara Therapeutics Inc (CDTX) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
XLV does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. XLV currently screens at market cap $0.
Not investment advice. Open the CDTX and XLV stock pages for the full models.
Not investment advice.